據報內險業償二代二期監管規則即將出台 明年首季起執行
據《券中社》報道,今年9月,中國銀保監會委務會議審議通過償二代二期工程20項監管規則及實施通知,目前相關文件已獲國務院同意,預計本月即可完成發文程序。
通知顯示,保險業將從2022年第一季度償付能力季度報告起統一執行新規則。對於受新規則影響較大的保險公司,中銀保監將按照一司一策原則確定過渡期政策,允許公司在部分監管規則上分步到位,最遲於2025年起全面執行到位。
據悉,保險公司可參考2021年7月第三輪聯動定量測試的規則版本,提前做好各項實施準備工作。受新規則影響較大的保險公司,目前可著手研究需要的過渡期政策並與中銀保監償付能力監管部溝通。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.